Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412588
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-09
Brief Title:
Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori EradicationA Prospective Multicenter Open-label Randomized Controlled Study
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Organization Data
Organization:
Nanjing First Hospital Nanjing Medical University
Class:
OTHER
Study ID:
KY20240123-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanjing First Hospital Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Zhenyu Zhang
Responsible Party Title:
Director of Gastroenterology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanjing First Hospital Nanjing Medical University
Old Name:
None
Old Organization:
None